Close
ELF™ Test (outside US only)
ELF*: The first CE marked Liver Fibrosis Marker Panel
Setting a New Standard in Liver Disease Testing
The ELF test is a simple, accurate, non-invasive blood test for measuring liver damage (known as fibrosis). It offers a quick straightforward method of providing valuable information:
- Minimal or no patient discomfort
- Identifies significant liver disease
- Monitors disease progression and response to therapy
Because ELF uses a blood sample rather than a biopsy, it can be used routinely for the same patient and helps monitor progression of fibrosis in the patient’s liver.
The ELF test - Three serum biomarkers
The ELF test combines three serum biomarkers which have been shown to correlate to the level of liver fibrosis assessed by liver biopsy. These biomarkers include:
- Hyaluronic acid (HA)
- Procollagen III amino terminal peptide (PIIINP)
- Tissue inhibitor of metalloproteinase 1 (TIMP-1)
The algorithm measures each of these markers by immunoassay, to create an ELF score. Sampling for the ELF test can be performed in a physician’s office or health center, avoiding the need for a patient to travel to a hospital.
Education Information
External Links
* The ELF test is only available outside the US
